Key points from article :
GlaxoSmithKline is ramping up its use of artificial intelligence to develop medicines of the future.
AI can speed the process up and increase the success rate of new medicines from 10% currently.
Recruiting 80 AI specialists, across London, Heidelberg, San Francisco, Philadelphia and Boston, by the end of 2020.
Includes PhD or master’s researchers in London under a new fellows programme.
Functional genomics looks at hundreds of millions of data points from genetic databases.
